(All fields required)
Please enter a valid email.
Please enter your name.
What is : (So we know you are human.)
Please supply the correct answer.
Thanks to the addition of faculty, the Cancer Biology and Neural Tumors Program has expanded its focus to investigate a wide range of diseases. Diseases under investigation include brain tumors (glioma), neurofibromatosis (neurofibroma and MPNST), RASopathies, rhabdomyosarcoma, neuroblastoma, squamous cell carcinoma and breast cancer.
One of the strengths of the group is our focus on the intersection between developmental biology and tumorigenesis, facilitated by location at a premier children’s hospital. Members of our group use genomic strategies to identify new oncogenes, tumor suppressors and signaling pathways that identify novel therapeutic targets, study metabolic links to cancer and use Phase 1 and Phase 2 compounds, including viral therapies, for testing in novel preclinical models.
We are also home to a P50 grant from the National Institutes of Health titled “Cincinnati Center for Neurofibromatosis Research,” which brings together scientists and clinicians to identify new pathways relevant to, and test therapies for, sarcoma (MPNST) in NF1.
FacultyNancy Ratner, PhD − program leaderLionel Chow, MD, PhDBiplab Dasgupta, PhDRashid Drissi, PhDKakajan Komurov, PhDRonald Waclaw, PhDSusanne Wells, PhDJianqiang Wu, MD
click to enlarge
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026 | 1-513-636-4200 | 1-800-344-2462 | TTY:1-513-636-4900
New to Cincinnati Children’s or live outside of the Tristate area? 1-877-881-8479
© 1999-2016 Cincinnati Children's Hospital Medical Center